-
January 7, 2022 4 NEW Psychedelics Trial Updates in 1 Day | Psilocybin, LSD, 18MC + Microdosing [MNMD, CMPS, FH]Whether or not psychedelic medicines will become legalized to treat patients with mental health conditions...
-
January 5, 2022 Mindset Pharma Teams Up with The McQuade Center to Develop 2 Families of Novel Psychedelic CompoundsIt’s yet another sign that the pharmaceutical industry at large is taking the potential of...
-
December 31, 2021 Psychedelic Business Spotlight – December 31This week in psychedelic business news: Mindset Pharma files another patent for compounds with "perfect...
-
December 30, 2021 2021: A Year in Review for the Psychedelics BusinessOur resident Psychedelic Investor looks back at some of this growing industry's biggest moments and...
-
December 30, 2021 Top 5 Psychedelics Milestones In 2021 & What To Expect in 2022 | Science, Funding, Stocks & MoreThe psychedelic medicines industry had a revolutionary year in 2021. At the start of the...
-
December 29, 2021 Interview with Matt Stang, CEO of Delic CorpCo-Founder and CEO, Matt Stang, gives us an overview of the company's clinics, Delic Labs...
-
December 24, 2021 Psychedelic Business Spotlight – December 24This week in psychedelic business news: FDA green lights a new psilocybin study; MindMed commences...
-
December 18, 2021 Breaking News: MindMed launches LSD Microdosing Trial Treating ADHD (Plus MNMD Stock Discussion)MindMed (Nasdaq:MNMD, NEO:MMED) has launched recruitment for their phase 2a clinical trial, testing using LSD...
-
December 17, 2021 Psychedelic Business Spotlight – December 17This week in psychedelic business news: Cybin steps closer to a new patent; MindMed appoints...
-
December 17, 2021 Mixing Psychedelics & Antidepressants: Is it Safe? | NEW Psilocybin StudyAs using psychedelics as medicines for mental health conditions has become more popular, it has...